Rare Disease Day is February 28. Primary sclerosing cholangitis or PSC is a rare liver disease characterized by progressive ...

These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of portal hypertension have been commissioned by the Clinical Services and Standards Committee (CSSC) ...

These include reduction in portal pressure, improved liver sinusoidal endothelial and hepatic microvascular ... prevention of liver injury following hypovolaemic shock and preventing/delaying ...

ADA indicates American Diabetes Association; NKF, National Kidney Foundation; ESH, European Society of Hypertension; and ESC, European Society of Cardiology. Adapted from Singer et al 48 with ...

is an important cause of bleeding in patients with cirrhosis associated with portal hypertension. Histologically, the condition is characterized by dilation of the mucosal and submucosal vessels ...

(AKRO), Monday, announced encouraging preliminary topline Week-96 results from a phase IIb trial of its investigational drug Efruxifermin in patients with compensated cirrhosis due to MASH (F4).

Weight-loss surgery lowers risk of developing complications of liver disease in patients with cirrhosis and obesity Bariatric surgery favorably influences progression of cirrhosis Date: January 27 ...

Objectives: This systematic review aim to evaluate the diagnostic accuracy of non-invasive methods for diagnosing portal hypertension and variceal bleeding in patients with NAFLD/MASLD cirrhosis, ...

These animals develop cirrhosis, portal hypertension, and HPS at 4–5 weeks after surgery. Most other animal models of cirrhosis, such as that induced by carbon tetrachloride, have not proved ...

About half of U.S. adults have high blood pressure, a major risk for heart attacks, strokes, kidney failure, even dementia. Many people don’t even realize they have hypertension until it’s done ...